ArticleAnnals of medicine and surgery (2012)2026
Relationship between prostate-specific antigen and prostate volume in benign enlargement of the prostate: a descriptive cross-sectional study.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Benign enlargement of the prostate (BEP) is a common urological condition among aging males, often leading to lower urinary tract symptoms and an increase in serum prostate-specific antigen (PSA) levels. The clinical challenge lies in distinguishing benign prostatic hyperplasia from prostate cancer, as both conditions elevate PSA levels. This study aims to investigate the correlation between prostate volume and PSA levels in BEP patients to refine diagnostic accuracy and improve management strategies. Methods: A prospective cross-sectional study was conducted on 100 patients diagnosed with BEP. Prostate volume was measured using transabdominal ultrasound, and serum PSA levels were recorded. Statistical analysis was performed to assess the correlation between prostate volume and PSA levels, controlling for confounders such as age and comorbidities. Results: The mean age of the patients was 71.92 ± 9.6 years, and the mean PSA level was 2.96 ± 2.36 ng/mL. The study population had a mean prostate volume of 56.19 ± 19.2 cc. The majority of patients presented with a combination of symptoms (27%), followed by poor urine stream (22%), incomplete voiding (19%), hesitancy (16%), nocturia (11%), and urinary incontinence (5%). Nearly half of the study population (49%) presented with grade 2 prostate enlargement. There was a positive correlation between prostate volume and PSA levels (rho = 0.729). The correlation between age and PSA levels was weakly positive (rho = 0.229), as was the correlation between age and prostate volume (rho = 0.26). Conclusion: There was a positive correlation between prostate volume and PSA levels (rho = 0.729). The correlation between patient age and PSA levels was weakly positive (rho = 0.229).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.